New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2012
10:00 EDTARW, CBL, EPR, FWLT, LPL, HSP, BCRX, XUE, AWROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Arrow Electronics (ARW) downgraded to Underperform from Outperform at CLSA... CBL & Associates (CBL) downgraded to Neutral from Buy at Goldman... Entertainment Properties (EPR) downgraded to Neutral from Buy at Goldman... Foster Wheeler (FWLT) downgraded to Neutral from Buy at Lazard Capital... Hospira (HSP) downgraded to Sell from Neutral at Goldman... LG Display (LPL) downgraded to Sell from Hold at Topeka... BioCryst (BCRX) downgraded to Hold from Buy at Noble Financial... Xueda Education (XUE) downgraded to Sell from Buy at Goldman... American States Water (AWR) downgraded to Neutral from Buy at Ladenburg.
News For ARW;CBL;EPR;FWLT;LPL;HSP;BCRX;XUE;AWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 27, 2014
11:24 EDTBCRXNovavax rises after announcing Ebola vaccine development program
Subscribe for More Information
07:27 EDTBCRXYoung NYC boy tested for Ebola, NY Post reports
Subscribe for More Information
07:22 EDTHSPAmerican College of Chest Physicians to hold a conference
Subscribe for More Information
October 26, 2014
14:40 EDTBCRXFDA issues Emergency Use Authorization for Ebola diagnostic tests
Subscribe for More Information
October 24, 2014
10:55 EDTBCRXDallas nurse now Ebola virus free, to be released, NBC reports
NBC and other media outlets cites NIH on Nina Pham's release. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED). Reference Link
October 23, 2014
15:25 EDTBCRXNew York confirms health care worker being tested for Ebola
Subscribe for More Information
14:58 EDTBCRXNew York doctor rushed to hospital with Ebola-like symptoms, NY Post reports
Subscribe for More Information
06:22 EDTBCRXEU to boost Ebola research with EUR 24.4M
The European Commission has today announced EUR 24.4M from the EU budget for urgently needed Ebola research. The funding will go to five projects, ranging from a large-scale clinical trial of a potential vaccine, to testing existing and novel compounds to treat Ebola. The money from Horizon 2020, the EU research and innovation program, will be provided via a fast-track procedure in order to start work as soon as possible. The Commission is also working with industry on the further development of vaccines, drugs and diagnostics for Ebola and other haemorrhagic diseases within the Innovative Medicines Initiative. The funding will be provided following proposals from teams across the EU and in numerous 3rd countries, which were evaluated by an independent group of experts. The Commission has also asked the European and Developing Countries Clinical Trials Partnership to include emerging epidemics of concern to Africa, including Ebola, in its work plan. This will allow to fund clinical trials on drugs, vaccines and diagnostics in upcoming calls. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED).
October 22, 2014
07:34 EDTFWLTFoster Wheeler unit awarded EPC contract for Exxon Mobil Antwerp refinery
Foster Wheeler (FWLT) announced that a subsidiary of its Global Engineering and Construction Group has been awarded an engineering, procurement, and constructioncontract by ExxonMobil (XOM) Petroleum & Chemical BVBA for the Antwerp Northwest Europe Resid Upgrade Project, Revamp and Offsites facilities at the Esso Antwerp Refinery at Antwerp, Belgium. Foster Wheeler's contract value was not disclosed. A small initial release of work was included in the company’s Q1 bookings. The full release of work was included in the company's Q2 bookings. Foster Wheeler’s scope of work is expected to be completed in December 2016.
07:21 EDTHSPU.S. DHS investigates medical gear for potential cyber defects, Reuters says
Subscribe for More Information
06:41 EDTBCRXWHO fast-tracking testing of two Ebola vaccines, Guardian reports
Subscribe for More Information
October 20, 2014
09:36 EDTLPL, LPLLG Display upgraded to Outperform from Sell at CLSA
Subscribe for More Information
09:09 EDTBCRXEMA encourages applications for orphan designation for Ebola treatments
The European Medicines Agency encourages developers of treatments or vaccines against Ebola to apply for orphan designation. Applications for orphan designation of Ebola medicines will be treated as a priority and EMA has committed to fast-tracking their evaluation, the regulator announced. Drug companies that are working on experimental Ebola vaccines and treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX), NewLink Genetics (NLNK) and GlaxoSmithKline (GSK).
08:04 EDTHSPGerman fund pressured to sell Mylan stake over drug used in executions, FT says
Subscribe for More Information
October 19, 2014
16:44 EDTBCRXEbola drug discovery efforts intensify, WSJ says
Subscribe for More Information
14:18 EDTHSPFresenius, others explore bid for Danone medical nutrition unit, Reuters says
Subscribe for More Information
13:39 EDTBCRXCarnival cruise passenger tests negative for Ebola, Reuters says
Subscribe for More Information
October 17, 2014
14:50 EDTBCRXBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
09:46 EDTBCRXSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
October 16, 2014
09:34 EDTLPLLG Display downgraded to Underperform from Neutral at Credit Suisse
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use